Merians D R, Haskell W L, Vranizan K M, Phelps J, Woods P D, Superko R
Am J Med. 1985 Jun;78(6 Pt 1):913-9. doi: 10.1016/0002-9343(85)90212-8.
To investigate the relationship of exercise and oral contraceptive use to plasma lipids and lipoproteins, a cross-sectional study was designed to compare lipid levels in 96 exercising and non-exercising women who used or did not use oral contraceptives. Exercisers had significantly lower plasma triglyceride concentrations and low-density/high-density lipoprotein ratios than non-exercisers after adjustment for differences in pill type distribution between groups. Women using progestin-dominant pills had significantly lower plasma triglyceride and high-density lipoprotein concentrations and significantly higher low-density/high-density lipoprotein ratios compared with women using estrogen/progestin-balanced pills. As body fat was significantly associated with both pill type and physical activity, it is unclear how much of these lipoprotein differences were due to body fat, exercise, or pill use. Regular physical activity together with reduced body fat partially compensated for plasma lipoprotein differences associated with oral contraceptive use.
为了研究运动和口服避孕药的使用与血浆脂质及脂蛋白之间的关系,设计了一项横断面研究,以比较96名使用或未使用口服避孕药的运动女性和非运动女性的脂质水平。在对两组之间避孕药类型分布的差异进行调整后,运动者的血浆甘油三酯浓度和低密度/高密度脂蛋白比率显著低于非运动者。与使用雌激素/孕激素平衡型避孕药的女性相比,使用以孕激素为主的避孕药的女性血浆甘油三酯和高密度脂蛋白浓度显著降低,低密度/高密度脂蛋白比率显著升高。由于体脂与避孕药类型和身体活动均显著相关,尚不清楚这些脂蛋白差异中有多少归因于体脂、运动或避孕药的使用。规律的体育活动与减少的体脂一起,部分补偿了与口服避孕药使用相关的血浆脂蛋白差异。